论文部分内容阅读
目的分析探讨急性脑梗死患者采用蘄蛇酶与依达拉奉联合用药的疗效。方法选取医院收治的急性脑梗死患者90例为研究对象,随机分为3组,每组30例。对照A组单用蘄蛇酶治疗,对照B组单用依达拉奉治疗,观察组采用蘄蛇酶联合依达拉奉治疗。治疗完毕,评估3组患者的治疗效果及神经功能缺损评分变化情况。结果观察组治疗后总有效率均高于对照A组及对照B组(P<0.05);观察组治疗后神经功能缺损评分低于治疗前及对照A组、对照B组治疗后(P<0.01)。结论针对急性脑梗死患者采用蘄蛇酶与依达拉奉联合治疗效果显著,值得在临床推广应用。
Objective To analyze the curative effect of combination therapy of viper and edaravone in patients with acute cerebral infarction. Methods Ninety patients with acute cerebral infarction admitted to the hospital were selected as study subjects and randomly divided into three groups (n = 30 in each group). The control group A was treated with viper alone, the control group B was treated with edaravone alone, and the observation group was treated with viper snake combined with edaravone. After the treatment was completed, the treatment effect and neurological deficit score of the three groups were evaluated. Results After treatment, the total effective rate in the observation group was significantly higher than that in the control group A and the control group B (P <0.05). The score of neurological deficit in the observation group after treatment was lower than that before treatment and control group A, ). Conclusion Acute cerebral infarction patients with viper snake enzyme and edaravone combination therapy is significant, it is worth in the clinical application.